Company intelligence / Profile preview

ViroVet

Leuven, Flemish Brabant, Belgiumvirovet.com ↗

Ownership: Private
Development stage: Preclinical

Overview

ViroVet develops innovative antiviral drugs and next-generation vaccines for the control of viral diseases affecting livestock. Its proprietary PLLAV vaccine technology enables rapid production of thermally stable live attenuated vaccines that do not require a cold chain. The company has demonstrated strong preclinical efficacy with its PRRS and Japanese encephalitis vaccines as well as antiviral agents against African Swine Fever. Several programs have shown promising results in animal challenge studies but are not yet commercially available.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Antiviral drugs (small molecules)Plasmid Launched Live Attenuated Virus (PLLAV) vaccines (genetic/vaccine platform)
Industry: Veterinary

Partnerships

The Pirbright Institute – collaboration on ASF antivirals developmentacademic collaborations with KU Leuven/Rega Institutecorporate contacts/collaborations with undisclosed animal health companies

Beyond the preview

Go deeper on ViroVet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViroVet.

Explore the full profile